DN
David Nierengarten Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
41
Avg Return
Past Year
Past Year
15%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
85.7%
Neutral
14.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Healthcare
Technology
Consumer Discretionary
Residential Construction
Restaurants
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Instruments & Supplies
Technology
Solar
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $110 |
22%
upside
| 1 | +21% |
0
%
| 17 Oct ‘25 2 days ago |
|
|
|
Outperform
Maintained
| $70 |
102%
upside
| 1 | +53% |
0
%
| 15 Oct ‘25 4 days ago |
|
|
|
Outperform
Maintained
| $880 |
4%
upside
| 1 | +11% |
0
%
| 13 Oct ‘25 6 days ago |
|
|
|
Outperform
Maintained
| $44 |
14%
upside
| 1 | +40% |
0
%
| 13 Oct ‘25 6 days ago |
|
|
|
Outperform
Reiterated
| $6 |
76%
upside
| 2 | +9.8% |
0
%
| 13 Oct ‘25 6 days ago |
|
|
|
Outperform
Initiated
| $4 |
121%
upside
| 1 | +17% |
0
%
| 8 Sep ‘25 1 month ago |
|
|
|
Outperform
Reiterated
| $115 |
24%
upside
| 1 | +14% |
0
%
| 8 Sep ‘25 1 month ago |
|
|
|
Outperform
Reiterated
| $26 |
76%
upside
| 2 | +45% |
0
%
| 2 Sep ‘25 1 month ago |
|
|
|
Outperform
Reiterated
| $22 |
104%
upside
| 1 | -14% |
0
%
| 28 Aug ‘25 1 month ago |
|
|
|
Outperform
Initiated
| $25 |
124%
upside
| 1 | +4.7% |
0
%
| 18 Aug ‘25 2 months ago |
|
|
|
Neutral
Downgraded
| $7 |
13%
upside
| 1 | – |
–
| 13 Aug ‘25 2 months ago |
|